Nurse-Midwifery & Women's Health Specialty Tracks in College of Nursing, The Ohio State University, Columbus, OH, USA.
Med Hypotheses. 2012 Feb;78(2):319-26. doi: 10.1016/j.mehy.2011.11.012. Epub 2011 Dec 3.
Oxytocin augmentation and cesarean rates among low-risk, term, nulliparous women with a spontaneous onset of labor in the United States approximate 50% and 26.5%, respectively. This indicates that the quality of obstetrical care is less than optimal in this nation. Exorbitant oxytocin use, the intervention most commonly associated with preventable adverse perinatal outcomes, jeopardizes birth safety while the high cesarean rate in this high-volume group compromises population health and increases health care costs. Dystocia, characterized by the slow, abnormal progression of labor, is the most commonly reported indication for primary cesareans, accounting directly for approximately 50% of all nulliparous cesareans and indirectly for most repeat cesareans. Diagnoses of dystocia are most often based on ambiguously defined delays in cervical dilation beyond which labor augmentation is deemed justified. Dystocia is known to be over-diagnosed which undoubtedly contributes to contemporary oxytocin augmentation and primary cesarean rates. Labor attendants would benefit from an evidence-based framework for homogenous labor assessment. To this end, we present a physiologically-based partograph for 'in-hospital' use in assessing the labors of low-risk, term, nulliparous women with spontaneous labor onset. This tool incorporates several evidence-based labor principles that combine to give needed clinical meaning to 'dystocia' as a diagnosis. It is hypothesized that our partograph will safely limit diagnoses of dystocia to only the slowest 10% of low-risk, nulliparous women. This should, in turn, safe-guard against unnecessary, injudicious, and potentially harmful use of oxytocin when labor is already adequately progressing while also indicating when its use may be justified. We further hypothesize that cesareans performed for dystocia in this population will decrease by ≥ 50%. No significant influence on other labor process or labor outcome variables is expected with partograph use. Widespread use of this physiologically-based partograph will be warranted if our hypotheses are supported.
在美国,自发性临产的低危、足月、初产妇中,催产素的应用率和剖宫产率分别约为 50%和 26.5%。这表明该国的产科护理质量不尽如人意。过度使用催产素是最常见的与可预防的围产儿不良结局相关的干预措施,这会危及分娩安全,而在这个高容量人群中,剖宫产率高则会影响人群健康并增加医疗保健成本。产程延长是指产程缓慢、异常进展,是初产妇行剖宫产的最常见指征,直接导致约 50%的初产妇行剖宫产,间接导致大多数再次剖宫产。产程延长的诊断通常基于宫颈扩张明显延迟的模糊定义,超过这一延迟就认为需要进行催产素引产。众所周知,产程延长的诊断被过度夸大,这无疑导致了当代催产素引产和初产妇剖宫产率的上升。分娩的护理人员将从基于证据的统一产程评估框架中受益。为此,我们提出了一种基于生理学的产程图,用于评估自发性临产的低危、足月、初产妇的产程。该工具纳入了几个基于证据的产程原则,将“产程延长”这一诊断赋予了所需的临床意义。我们假设,我们的产程图将安全地将产程延长的诊断限制在仅最慢的 10%的低危初产妇中。这反过来又可以防止在产程已经充分进展时不必要、不明智且可能有害地使用催产素,同时也表明何时可以合理使用。我们还假设,在这种人群中,因产程延长而行剖宫产的比例将下降≥50%。预计使用产程图不会对其他产程过程或产程结局变量产生显著影响。如果我们的假设得到支持,广泛使用这种基于生理学的产程图将是合理的。